Concepedia

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

Michael R. McClung, Michelle L. O’Donoghue, Socrates E. Papapoulos, Henry G. Bone, Bente Langdahl, Kenneth G. Saag, Ian R. Reid, Douglas P. Kiel, Ilaria Cavallari, Marc P. Bonaca,

The Lancet Diabetes & Endocrinology · 2019 · 169 citations · 27 references

DOI

Concepts

References

27

Incidence and Economic Burden of Osteoporosis-Related Fractures in the United States, 2005–2025

Russel Burge, Bess Dawson‐Hughes, Daniel H. Solomon et al. · Journal of Bone and Mineral Research · 2006 · 4K citations

, , +16

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures

Dennis M. Black, Steven R. Cummings, David Karpf et al. · The Lancet · 1996 · 3.9K citations

, , +12

Vertebral fracture assessment using a semiquantitative technique

Harry K. Genant, Chun‐Ying Wu, Cornelis van Kuijk et al. · Journal of Bone and Mineral Research · 1993 · 3.7K citations

, , +13

Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

Steven R. Cummings, Javier San Martín, Michael R. McClung et al. · New England Journal of Medicine · 2009 · 3.4K citations · Full text

, , +12

Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis

Dennis M. Black, Pierre D. Delmas, Richard Eastell et al. · New England Journal of Medicine · 2007 · 3K citations · Full text

, , +16